文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

在体研究中 decorin 在角膜新生血管化中的功能作用。

The functional role of decorin in corneal neovascularization in vivo.

机构信息

Harry S. Truman Memorial Veterans' Hospital, Columbia, MO, United States; One-Health Vision Research Program, Departments of Veterinary Medicine & Surgery and Biomedical Sciences, College of Veterinary Medicine, University of Missouri, Columbia, MO, United States.

Harry S. Truman Memorial Veterans' Hospital, Columbia, MO, United States; One-Health Vision Research Program, Departments of Veterinary Medicine & Surgery and Biomedical Sciences, College of Veterinary Medicine, University of Missouri, Columbia, MO, United States; Mason Eye Institute, School of Medicine, University of Missouri, Columbia, MO, United States.

出版信息

Exp Eye Res. 2021 Jun;207:108610. doi: 10.1016/j.exer.2021.108610. Epub 2021 Apr 30.


DOI:10.1016/j.exer.2021.108610
PMID:33940009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9250794/
Abstract

Our earlier decorin (Dcn) gene overexpression studies found that the targeted Dcn gene transfer into the cornea inhibited corneal angiogenesis in vivo using a rabbit model. In this study, we tested the hypothesis that anti-angiogenic effects of decorin in the cornea are mediated by alterations in a normal physiologic balance of pro- and anti-angiogenic factors using decorin deficient (Dcn) and wild type (Dcn) mice. Corneal neovascularization (CNV) in Dcn and Dcn mice was produced with a standard chemical injury technique. The clinical progression of CNV in mice was monitored with stereo- and slit-lamp microscopes, and histopathological hematoxylin and eosin (H&E) staining. Protein and mRNA expression of pro- and anti-angiogenic factors in the cornea were evaluated using immunofluorescence and quantitative real-time PCR, respectively. Slit-lamp clinical eye examinations revealed significantly more CNV in Dcn mice than the Dcn mice post-injury (p < 0.05) and AAV5-Dcn gene therapy significantly reduced CNV in Dcn mice compered to no AAV5-Dcn gene therapy controls (p < 0.001). H&E-stained corneal sections exhibited morphology with several neovessels in injured corneas of the Dcn mice than the Dcn mice. Immunofluorescence of corneal sections displayed significantly higher expression of α-smooth muscle actin (α-SMA) and endoglin proteins in Dcn mice than Dcn mice (p < 0.05). Quantitative real-time PCR found significantly increased mRNA levels of pro-angiogenic factors endoglin (2.53-fold; p < 0.05), Vegf (2.47-fold; p < 0.05), and Pecam (2.14-fold; p < 0.05) and anti-angiogenic factor Vegfr2 (1.56-fold; p < 0.05) in the normal cornea of the Dcn mice than the Dcn mice. Furthermore, neovascularized Dcn mice corneas showed greater increase in mRNA expression of pro-angiogenic factors endoglin (4.58-fold; p < 0.0001), Vegf (4.16-fold; p < 0.0001), and Pdgf (2.15-fold; p < 0.0001) and reduced expression of anti-angiogenic factors Ang2 (0.12-fold; p < 0.05), Timp1 (0.22-fold; p < 0.05), and Vegfr2 (0.67-fold; p > 0.05) compared to neovascularized Dcn mice corneas. These gene deficience studies carried with transgenic Dcn mice revealed decorin's role in influencing a physiologic balance between pro-and anti-angiogenic factors in the normal and injured cornea. We infer that the functional deletion of Dcn promotes irregular corneal repair and aggravates CNV.

摘要

我们之前的核心蛋白聚糖(Dcn)基因过表达研究发现,使用兔模型,将靶向 Dcn 基因转移到角膜中可抑制体内角膜血管生成。在这项研究中,我们使用核心蛋白聚糖缺乏(Dcn)和野生型(Dcn)小鼠测试了这样一个假设,即核心蛋白聚糖在角膜中的抗血管生成作用是通过改变正常的促血管生成和抗血管生成因子的生理平衡来介导的。使用标准的化学损伤技术在 Dcn 和 Dcn 小鼠中产生角膜新生血管(CNV)。使用立体显微镜和裂隙灯显微镜监测小鼠 CNV 的临床进展,并进行苏木精和伊红(H&E)染色的组织病理学检查。使用免疫荧光和定量实时 PCR 分别评估角膜中促血管生成和抗血管生成因子的蛋白和 mRNA 表达。裂隙灯临床眼部检查显示,与 Dcn 小鼠相比,Dcn 小鼠的 CNV 明显更多(p < 0.05),并且 AAV5-Dcn 基因治疗可显著减少 Dcn 小鼠的 CNV,与无 AAV5-Dcn 基因治疗对照相比(p < 0.001)。H&E 染色的角膜切片显示,与 Dcn 小鼠相比,Dcn 小鼠受伤角膜中有更多的新生血管。角膜切片的免疫荧光显示,Dcn 小鼠中 α-平滑肌肌动蛋白(α-SMA)和内源性蛋白的表达明显高于 Dcn 小鼠(p < 0.05)。定量实时 PCR 发现,Dcn 小鼠正常角膜中促血管生成因子内源性蛋白(2.53 倍;p < 0.05)、Vegf(2.47 倍;p < 0.05)和 Pecam(2.14 倍;p < 0.05)和抗血管生成因子 Vegfr2(1.56 倍;p < 0.05)的 mRNA 水平明显升高。此外,新生血管化的 Dcn 小鼠角膜中促血管生成因子内源性蛋白(4.58 倍;p < 0.0001)、Vegf(4.16 倍;p < 0.0001)和 Pdgf(2.15 倍;p < 0.0001)的 mRNA 表达增加更大,抗血管生成因子 Ang2(0.12 倍;p < 0.05)、Timp1(0.22 倍;p < 0.05)和 Vegfr2(0.67 倍;p > 0.05)的表达减少。与新生血管化的 Dcn 小鼠角膜相比。这些带有转基因 Dcn 小鼠的基因缺陷研究揭示了核心蛋白聚糖在影响正常和受伤角膜中促血管生成和抗血管生成因子之间生理平衡方面的作用。我们推断,Dcn 的功能缺失会促进不规则的角膜修复并加重 CNV。

相似文献

[1]
The functional role of decorin in corneal neovascularization in vivo.

Exp Eye Res. 2021-6

[2]
Tissue-targeted and localized AAV5-DCN and AAV5-PEDF combination gene therapy abrogates corneal fibrosis and concurrent neovascularization in rabbit eyes in vivo.

Ocul Surf. 2024-4

[3]
Decorin regulates collagen fibrillogenesis during corneal wound healing in mouse in vivo.

Exp Eye Res. 2022-3

[4]
Targeted decorin gene therapy delivered with adeno-associated virus effectively retards corneal neovascularization in vivo.

PLoS One. 2011-10-19

[5]
Inhibition of mouse alkali burn induced-corneal neovascularization by recombinant adenovirus encoding human vasohibin-1.

Mol Vis. 2010-7-26

[6]
Six-Month In Vivo Safety Profiling of Topical Ocular AAV5-Decorin Gene Transfer.

Transl Vis Sci Technol. 2021-8-12

[7]
Characterization of C-X-C chemokine receptor type 5 in the cornea and role in the inflammatory response after corneal injury.

Exp Eye Res. 2023-1

[8]
The role of PDGF receptor inhibitors and PI3-kinase signaling in the pathogenesis of corneal neovascularization.

Invest Ophthalmol Vis Sci. 2006-5

[9]
Critical role of TNF-α-induced macrophage VEGF and iNOS production in the experimental corneal neovascularization.

Invest Ophthalmol Vis Sci. 2012-6-14

[10]
Protective Effect of TLR4 Ablation against Corneal Neovascularization following Chemical Burn in a Mouse Model.

Curr Eye Res. 2019-1-24

引用本文的文献

[1]
Proteoglycans and glycosaminoglycans: critical regulators in angiogenesis, vasculogenesis, and vascularized tissue engineering.

Angiogenesis. 2025-6-25

[2]
Adipose-derived stem cell exosomes alleviate TGF-β1-induced urethral stricture fibrosis by suppressing the TGF-β/Smad pathway and downstream PDGFR-β/RAS/ERK signaling.

J Cell Commun Signal. 2025-6-12

[3]
Comprehensive investigation of proteoglycan gene expression in breast cancer: Discovery of a unique proteoglycan gene signature linked to the malignant phenotype.

Proteoglycan Res. 2025

[4]
Analysis of Smad3 in the modulation of stromal extracellular matrix proteins in corneal scarring after alkali injury.

Mol Vis. 2024-12-30

[5]
Transcriptomic landscape of quiescent and proliferating human corneal stromal fibroblasts.

Exp Eye Res. 2024-11

[6]
TGF-β-Based Therapies for Treating Ocular Surface Disorders.

Cells. 2024-6-26

[7]
Decorin suppresses tumor lymphangiogenesis: A mechanism to curtail cancer progression.

Proc Natl Acad Sci U S A. 2024-4-30

[8]
Global impact of proteoglycan science on human diseases.

iScience. 2023-10-4

[9]
Toxicological effects of ocular acrolein exposure to eyelids in rabbits in vivo.

Exp Eye Res. 2023-9

[10]
Small leucine rich proteoglycans: Biology, function and their therapeutic potential in the ocular surface.

Ocul Surf. 2023-7

本文引用的文献

[1]
Is sex a biological variable in corneal wound healing?

Exp Eye Res. 2019-6-18

[2]
Role of Angiopoietin-2 in Vascular Physiology and Pathophysiology.

Cells. 2019-5-17

[3]
Current and emerging therapies for corneal neovascularization.

Ocul Surf. 2018-6-20

[4]
Endoglin interacts with VEGFR2 to promote angiogenesis.

FASEB J. 2018-1-11

[5]
Recent drug therapies for corneal neovascularization.

Chem Biol Drug Des. 2017-11

[6]
Decorin interacting network: A comprehensive analysis of decorin-binding partners and their versatile functions.

Matrix Biol. 2016-9

[7]
Pivotal role for decorin in angiogenesis.

Matrix Biol. 2015-4

[8]
Nanoparticle-mediated expression of a Wnt pathway inhibitor ameliorates ocular neovascularization.

Arterioscler Thromb Vasc Biol. 2015-4

[9]
Three-year corneal graft survival rate in high-risk cases treated with subconjunctival and topical bevacizumab.

Graefes Arch Clin Exp Ophthalmol. 2015-2

[10]
Bevacizumab eye drops delay corneal epithelial wound healing and increase the stromal response to epithelial injury in rats.

Clin Exp Ophthalmol. 2013-4-11

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索